These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9786099)

  • 21. Patterns of prescription antihypertensive drug utilization and adherence to treatment guidelines in the city of Novi Sad.
    Tomas A; Tomić Z; Milijasević B; Ban M; Horvat O; Vukmirović S; Sabo A
    Vojnosanit Pregl; 2016 Jun; 73(6):531-7. PubMed ID: 27498444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of digoxin, diuretics, beta blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers in older patients in an academic hospital-based geriatrics practice.
    Fishkind D; Paris BE; Aronow WS
    J Am Geriatr Soc; 1997 Jul; 45(7):809-12. PubMed ID: 9215330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of ACE inhibitors and ARBs in hypertensive women of childbearing age.
    Martin U; Foreman MA; Travis JC; Casson D; Coleman JJ
    J Clin Pharm Ther; 2008 Oct; 33(5):507-11. PubMed ID: 18834365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue angiotensin-converting enzyme inhibitors: are they more effective than serum angiotensin-converting enzyme inhibitors?
    Shah AD; Arora RR
    Clin Cardiol; 2005 Dec; 28(12):551-5. PubMed ID: 16405197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temporal trends in pharmacotherapy for congestive heart failure at an academic medical center: 1990-1995.
    Rich MW; Brooks K; Luther P
    Am Heart J; 1998 Mar; 135(3):367-72. PubMed ID: 9506320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term and short-term changes in antihypertensive prescribing by office-based physicians in the United States.
    Stafford RS; Monti V; Furberg CD; Ma J
    Hypertension; 2006 Aug; 48(2):213-8. PubMed ID: 16785334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta-blockers and angiotensin-converting enzyme inhibitors/receptor blockers prescriptions after hospital discharge for heart failure are associated with decreased mortality in Alberta, Canada.
    Johnson D; Jin Y; Quan H; Cujec B
    J Am Coll Cardiol; 2003 Oct; 42(8):1438-45. PubMed ID: 14563589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of angiotensin-converting enzyme inhibitors in the treatment of heart failure in hospital practice.
    Missouris CG; MacGregor GA
    Postgrad Med J; 1997 Jul; 73(861):409-11. PubMed ID: 9338025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managing heart failure in primary care: first steps in implementing the National Service Framework.
    Gnani S; Gray J; Khunti K; Majeed A
    J Public Health (Oxf); 2004 Mar; 26(1):42-7. PubMed ID: 15044573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does Angiotensin-Converting Enzyme Inhibitor and β-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink.
    Hagberg KW; Sahasrabuddhe VV; McGlynn KA; Jick SS
    Pharmacotherapy; 2016 Feb; 36(2):187-95. PubMed ID: 26846893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation of Infarct Size. Thrombolysis in Myocardial Infarction.
    Kizer JR; Cannon CP; McCabe CH; Mueller HS; Schweiger MJ; Davis VG; Perritt R; Antman EM
    Am Heart J; 1999 Jan; 137(1):79-92. PubMed ID: 9878939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin II and trials of cardiovascular outcomes.
    Sleight P
    Am J Cardiol; 2002 Jan; 89(2A):11A-16A; discussion 16A-17A. PubMed ID: 11835905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease.
    Lipworth B; Skinner D; Devereux G; Thomas V; Ling Zhi Jie J; Martin J; Carter V; Price DB
    Heart; 2016 Dec; 102(23):1909-1914. PubMed ID: 27380949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cluster randomized trial to assess the impact of opinion leader endorsed evidence summaries on improving quality of prescribing for patients with chronic cardiovascular disease: rationale and design [ISRCTN26365328].
    Majumdar SR; McAlister FA; Tsuyuki RT
    BMC Cardiovasc Disord; 2005 Jun; 5(1):17. PubMed ID: 15982421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ACE inhibitors and heart failure in hospital: any difference between cardiologists and general physicians?
    Davie AP; McMurray JJ
    Postgrad Med J; 1999 Apr; 75(882):219-2. PubMed ID: 10715761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Misperceptions about beta-blockers and diuretics: a national survey of primary care physicians.
    Ubel PA; Jepson C; Asch DA
    J Gen Intern Med; 2003 Dec; 18(12):977-83. PubMed ID: 14687255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin AT-1 receptor antagonism: complementary or alternative to ACE inhibition in cardiovascular and renal disease?
    Doggrell SA
    Expert Opin Pharmacother; 2002 Nov; 3(11):1543-56. PubMed ID: 12437489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Provider factors influencing prescriptions of recommended antihypertensive medications among patients with diabetes and hypertension
.
    Kang HJ; Song I; Kim YY; Park JH; Ha S; Jang S
    Int J Clin Pharmacol Ther; 2019 Aug; 57(8):393-401. PubMed ID: 31131826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of pharmacist intervention on prescribing of angiotensin-converting-enzyme inhibitors, angiotensin II-receptor blockers, and aspirin for diabetic patients.
    LaMarr B; Valdez C; Driscoll K; Ryan M
    Am J Health Syst Pharm; 2010 Feb; 67(4):290-4. PubMed ID: 20133534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rational pharmacotherapy of hypertension in the elderly: analysis of the choice and dosage of drugs.
    Jassim Al Khaja KA; Sequeira RP; Mathur VS
    J Clin Pharm Ther; 2001 Feb; 26(1):33-42. PubMed ID: 11286605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.